Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer's disease patients

被引：0
|
作者：
Chatanaka, Miyo K. [1 ]
Prassas, Ioannis [2 ]
Diamandis, Eleftherios P. [3 ]
机构：
[1] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[2] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada
[3] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
来源：
BMC MEDICINE | 2024年 / 22卷 / 01期
关键词：
Alzheimer's disease; Biomarker; Non-invasive; SMOC1; Neuropentraxin; Diagnostic test; Reference range;
D O I：
10.1186/s12916-024-03270-w
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this commentary, we address a paper published by Johnson et al. by assessing the robustness of their method to discover diagnostic biomarkers in Alzheimer's disease (AD). In addition, we examine how these newly discovered and previously discovered biomarkers, can play a role in assisting patients with AD and those at risk for developing AD, with an emphasis on the translational hurdles that accompany such discoveries.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease
    Lusardi, Theresa A.
    Phillips, Jay I.
    Wiedrick, Jack T.
    Harrington, Christina A.
    Lind, Babett
    Lapidus, Jodi A.
    Quinn, Joseph F.
    Saugstad, Julie A.
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (03) : 1223 - 1233
  • [42] Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease
    Skogseth, Ragnhild
    Mulugeta, Ezra
    Ballard, Clive
    Rongve, Arvid
    Nore, Sabine
    Alves, Guido
    Aarsland, Dag
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (06) : 559 - 563
  • [43] The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer's Disease
    Engelborghs, Sebastiaan
    Le Bastardl, Nathalie
    MOLECULAR DIAGNOSIS & THERAPY, 2012, 16 (03) : 135 - 141
  • [44] To tap or not to tap: Cerebrospinal fluid biomarkers of Alzheimer's disease
    Growdon, JH
    ANNALS OF NEUROLOGY, 1998, 44 (01) : 6 - 7
  • [45] Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid
    Riekse, Robert G.
    Li, Ge
    Petrie, Eric C.
    Leverenz, James B.
    Vavrek, Darcy
    Vuletic, Simona
    Albers, John J.
    Montine, Thomas J.
    Lee, Virginia M. -Y.
    Lee, Michael
    Seubert, Peter
    Galasko, Douglas
    Schellenberg, Gerard D.
    Hazzard, William R.
    Peskind, Elaine R.
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 10 (04) : 399 - 406
  • [46] Reply: Cerebrospinal fluid proteomics for biomarkers of Alzheimer's disease
    Lee, Kelvin H.
    Relkin, Norman R.
    ANNALS OF NEUROLOGY, 2007, 61 (05) : 497 - 498
  • [47] A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium
    Somers, Charisse
    Struyfs, Hanne
    Goossens, Joery
    Niemantsverdriet, Ellis
    Luyckx, Jill
    De Roeck, Naomi
    De Roeck, Ellen
    De Vil, Bart
    Cras, Patrick
    Martin, Jean-Jacques
    De Deyn, Peter-Paul
    Bjerke, Maria
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (01) : 383 - 395
  • [48] Cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
    Kolupaeva, E.
    Zhukova, I.
    Zhukova, N.
    Alifirova, V.
    Izhboldina, O.
    Mironova, Y.
    Latypova, A.
    Nikitina, M.
    Titova, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 673 - 673
  • [49] Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer's disease
    Olsson, Martin
    Arlig, Johan
    Hedner, Jan
    Blennow, Kaj
    Zetterberg, Henrik
    SLEEP, 2018, 41 (05)
  • [50] Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid of Spanish Patients With Mild Cognitive Impairment
    Monge-Argiles, J. A.
    Munoz-Ruiz, C.
    Pampliega-Perez, A.
    Gomez-Lopez, M. J.
    Sanchez-Paya, J.
    Borja, E. Rodriguez
    Ruiz-Vegara, M.
    Montoya-Gutierrez, F. J.
    Leiva-Santana, C.
    NEUROCHEMICAL RESEARCH, 2011, 36 (06) : 986 - 993
12345